Key result
Redo SAVR addresses a failed transcatheter valve-in-valve procedure in a 76-year-old female.
Why the study?
Placing TAVR in a small bioprosthesis (<23 mm) during a valve-in-valve procedure can lead to delayed dysfunction of the prosthetic valve.
Case Report (n=1)
This case demonstrates the feasibility of redo surgical aortic valve replacement for delayed dysfunction of a TAVR valve-in-valve placed in a small bioprosthesis.
Highlights surgical rescue for late ViV TAVR failure in small annuli; leaves open need for larger series on outcomes.
Transcatheter aortic valve replacement (TAVR) has become the preferred intervention for patients with severe aortic stenosis and significant comorbidities. This technique can also be used for failed bioprosthetic valves and is known as the valve-in-valve (ViV) procedure. Placing TAVR in a small bioprosthesis (<23 mm) can lead to delayed dysfunction of the prosthetic valve. We present a case of a late explanted ViV 8 years post-initial aortic valve replacement and coronary artery bypass grafting, and 3 years post-ViV procedure in a 76-year-old female. A video of the surgical procedure is provided.
No takes yet. Share an insight, caveat, or question.
Tavilla et al. (2022) conducted a case report in prosthetic valve valve-in-valve dysfunction (n=1). Redo surgical aortic valve replacement was evaluated. Redo surgical aortic valve replacement was performed for a failed transcatheter valve-in-valve procedure in a 76-year-old female.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: